Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1798
0.00 (0.00%)
Jun 4, 2025, 3:00 PM - Market open

Ernexa Therapeutics Statistics

Total Valuation

ERNA has a market cap or net worth of $11.21 million. The enterprise value is $12.18 million.

Market Cap 11.21M
Enterprise Value 12.18M

Important Dates

The next estimated earnings date is Friday, June 13, 2025, after market close.

Earnings Date Jun 13, 2025
Ex-Dividend Date n/a

Share Statistics

ERNA has 62.36 million shares outstanding. The number of shares has increased by 376.06% in one year.

Current Share Class 62.36M
Shares Outstanding 62.36M
Shares Change (YoY) +376.06%
Shares Change (QoQ) +39.11%
Owned by Insiders (%) 62.14%
Owned by Institutions (%) 4.42%
Float 17.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.62
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 22.77
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio 0.21
Quick Ratio 0.20
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.38

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -32.42%
Return on Invested Capital (ROIC) -43.30%
Return on Capital Employed (ROCE) 263.86%
Revenue Per Employee $89,167
Profits Per Employee -$7.69M
Employee Count 6
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, ERNA has paid $34,000 in taxes.

Income Tax 34,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -90.54% in the last 52 weeks. The beta is 7.12, so ERNA's price volatility has been higher than the market average.

Beta (5Y) 7.12
52-Week Price Change -90.54%
50-Day Moving Average 0.21
200-Day Moving Average 0.62
Relative Strength Index (RSI) 35.16
Average Volume (20 Days) 429,204

Short Selling Information

The latest short interest is 127,421, so 0.20% of the outstanding shares have been sold short.

Short Interest 127,421
Short Previous Month 104,315
Short % of Shares Out 0.20%
Short % of Float 0.73%
Short Ratio (days to cover) 0.70

Income Statement

In the last 12 months, ERNA had revenue of $535,000 and -$46.11 million in losses. Loss per share was -$1.80.

Revenue 535,000
Gross Profit 500,000
Operating Income -14.19M
Pretax Income -22.90M
Net Income -46.11M
EBITDA -14.08M
EBIT -14.19M
Loss Per Share -$1.80
Full Income Statement

Balance Sheet

The company has $1.92 million in cash and $2.88 million in debt, giving a net cash position of -$964,000 or -$0.02 per share.

Cash & Cash Equivalents 1.92M
Total Debt 2.88M
Net Cash -964,000
Net Cash Per Share -$0.02
Equity (Book Value) -5.95M
Book Value Per Share -0.11
Working Capital -8.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.15 million and capital expenditures -$268,000, giving a free cash flow of -$14.42 million.

Operating Cash Flow -14.15M
Capital Expenditures -268,000
Free Cash Flow -14.42M
FCF Per Share -$0.23
Full Cash Flow Statement

Margins

Gross Margin 93.46%
Operating Margin -2,652.90%
Pretax Margin -8,609.35%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ERNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -376.06%
Shareholder Yield -376.06%
Earnings Yield -410.99%
FCF Yield -128.55%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on October 17, 2022. It was a reverse split with a ratio of 0.05:1.

Last Split Date Oct 17, 2022
Split Type Reverse
Split Ratio 0.05:1

Scores

ERNA has an Altman Z-Score of -76.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -76.66
Piotroski F-Score 3